Checkpoint Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Checkpoint Therapeutics

12/08/2024 22:01

* Checkpoint Therapeutics Inc  CKPT.OQ  reported a quarterly
adjusted loss of 18 cents​​ per share for the quarter ended in
June, higher than the same quarter last year, when the company
reported EPS of $-1.05.  The mean expectation of three analysts
for the quarter was for a loss of 30 cents per share. Wall
Street expected results to range from -32 cents to -29 cents per
share.
    * Revenue rose 32.3% to $41.00 thousand from a year ago;
analysts
expected $15.50 thousand. 
    * Checkpoint Therapeutics Inc's reported EPS for the quarter
was a
loss of 18 cents​.
    * The company reported a quarterly loss of $6.67 million.
    * Checkpoint Therapeutics Inc shares had risen by 4.7% this
quarter and lost 1.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 7.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Checkpoint
Therapeutics Inc is $27.00 
This summary was machine generated from LSEG data August 12 at
09:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.30          -0.18          Beat
 Mar. 31 2024      -0.27          -0.33          Missed
 Dec. 31 2023      -0.54          -1.10          Missed
 Sep. 30 2023      -0.76          -0.29          Beat